3VM for Treatment of Chronic Osteoarthritis Knee Pain
Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
A double-blind, placebo-controlled, randomized dose ranging study for the use of 3VM1001
Cream, 2g three times daily, 3g three times daily, or 3g four times daily for treatment of
chronic pain associated with osteoarthritis of the knee compared to inactive placebo.